Dr. Al-Hilal joined the College of Pharmacy as a joint tenure-track faculty between Molecular Pharmaceutics and Biomedical Engineering departments.
Dr. Al-Hilal obtained his PhD degree in 2014 from the Department of Pharmaceutical Sciences, Seoul National University, South Korea. He then did postdoctoral training at Texas Tech and Mass General Hospital. In 2019 he started his independent faculty position at the University of Texas El-Passo in the Department of Pharmaceutical Science before moving to Utah.
Dr. Al-Hilal has published over 40 research articles. Current projects in his lab are focusing to understand: 1) Role of a prion-like protein Doppel in tumor microenvironment and progression; 2) Role of tumor-coagulome in immunosuppression; 3) Ovarian cancer disparity and heterogeneity using an ascitic-fluid derived organoid model; and 4) Cell-specific Durotaxis (cells movement up against stiffness gradient) in fibrotic lung diseases.
Education History
| Graduate Training |
Seoul National University |
Masters of Pharmacy |
|---|---|---|
|
Seoul National University |
PhD, Pharmaceutical Sciences | |
| Postdoctoral Training |
Texas Tech University Health Sciences Center |
Postdoctoral Research |
|
Massachusetts General Hospital/Harvard |
Postdoctoral Research |
Selected Publications
Journal Article
-
Multi-purposable filaments of HPMC for 3D printing of medications with tailored drug release and timed-absorption. Hossam Kadry, Taslim A Al-Hilal, Ali Keshavarz, Farzana Alam, Changxue Xu, Abraham Joy, Fakhrul Ahsan. International journal of pharmaceutics. 2018
-
Oral drug delivery systems using chemical conjugates or physical complexes.Taslim A Al-Hilal, Farzana Alam, Youngro Byun. Advanced drug delivery reviews. 2013
-
Engineered nanodelivery systems to improve DNA vaccine technologies. Michael Lim, Abu Zayed Md Badruddoza, Jannatul Firdous, Mohammad Azad, Adnan Mannan, Taslim Ahmed Al-Hilal, Chong-Su Cho, Mohammad Ariful Islam. Pharmaceutics. 2020